Luteal Phase Defect Clinical Trial
Official title:
Prospective, Randomised, Double-blind, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of 25 mg Natural Progesterone Administered Subcutaneously in Restoring the Normal Luteal Phase in Women With Previous Diagnosis of Luteal Phase Deficiency
The main objective of this study will be to assess the efficacy of natural progesterone at a
daily dose of 25 mg in restoring a normal luteal phase. The primary end-point will be the
ongoing pregnancy rate.
The secondary objectives will be the rate of endometrial biopsy showing an in phase
endometrium after 3 months of treatment.
The length of the luteal phase of the menstrual cycle after treatment will also be assessed
and compared with the initial duration (from LH peak to onset of menstruation).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01178931 -
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support
|
N/A | |
Completed |
NCT04174378 -
Luteal Phase Support In IVF Women Using GnRH Agonist
|
||
Completed |
NCT04938622 -
Bioenergetics of Exercise-Induced Menstrual Disturbances
|
N/A | |
Completed |
NCT04722471 -
Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.
|
||
Completed |
NCT02458404 -
Effects of Varied Estrogen Doses on Endometrial Receptivity
|
||
Completed |
NCT05107804 -
Energy Restriction and Hormones in Premenopausal Women
|
N/A | |
Completed |
NCT03948022 -
Luteal Support in Frozen-Thawed Embryo Transfer Cycles
|
Phase 4 | |
Not yet recruiting |
NCT05080569 -
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
|
Phase 4 | |
Recruiting |
NCT04806919 -
Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone
|
Phase 3 |